stage

Country: United States

Premium Shoe Insoles

Premium Shoe Insoles

location_on Queensland , Australia

Overview Pitch Details The Team Documents

Please note:
Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Investors are encouraged to review and evaluate the investments and determine at their own discretion, the appropriateness of making the particular investment. The information on this website is provided for informational purposes only, but we cannot guarantee that the information is accurate or complete. We strongly encourage investors to complete their own due diligence with licensed professionals, prior to making any investment and will not offer any legal or tax advice.

Short Summary

OrthoSwiss Australia consist of 2 businesses: 1. Selling premium insole material to podiatrists, 2. A Production Centre that produces insoles for the Measuring locations.

Highlights

Premium EVA material in the market
Most precise and reliable foot profil measurement with the Digitizer
Existing customers with yearly turnover

Overview

Target	$275,000
Minimum	$65,000
Investment Raised	$0
Previous Rounds	$0
Stage	Achieving Sales
Investor Role	Any

Ask a question
Have a question?

Similar Projects

BBKItty: Baby Comfort

location_onLuzon, Philippines

BB Kitty is the first diaper brand in the Philippines to sell per piece; We cater to Filipinos’ “try first” buying behavior and affordability concerns. Our eCommerce & retail strategy makes premium diapers accessible to all.

First diaper brand selling per piece in the Philippines.
Massive demand – ₱58B market with 1.85M+ births yearly.
Affordable premium brand disrupting a bulk-pack industry.

$175,000

Total Required

$2,000

Min per Investor

Entac Medical Inc.

location_onSouth East, United States

Entac develops AI-driven acoustic wearables predicting patient adverse events, with its first launched device, PrevisEA, targeting an $8 billion market and a pipeline for multiple high-value healthcare sectors exceeding $20 billion.

PrevisEA Commitments: 5 hospitals systems (63 hospitals) $41M revenue oppy
In review: 6 systems (71 hospitals) - $39M opportunity. Commitment due
Engaged: 7 systems (120 hospitals) - $67M opportunity - Expected in 2025.

$2,000,000

Total Required

$50,000

Min per Investor

Extend Robotics

location_onLondon, United Kingdom

Robotic Software | Teleoperation & AI We build extended reality (XR) interface Saas software to empower embodied AI and humanoids to learn in the real world, by combining remote operation & data for training. Raised £500,000✅ EIS eligible✅

Fast-growing SaaS Cloud Software Business with Breakthrough Patented Tech
Best-in-class Data Engine Enabling Embodied AI Learning after $6Bn Market
Early Adopter Validated Product with Revenue Growth average 100% YoY

$1,400,000

Total Required

$25,000

Min per Investor